[go: up one dir, main page]

WO2009054483A1 - Medicament contenant de la salusine-β - Google Patents

Medicament contenant de la salusine-β Download PDF

Info

Publication number
WO2009054483A1
WO2009054483A1 PCT/JP2008/069307 JP2008069307W WO2009054483A1 WO 2009054483 A1 WO2009054483 A1 WO 2009054483A1 JP 2008069307 W JP2008069307 W JP 2008069307W WO 2009054483 A1 WO2009054483 A1 WO 2009054483A1
Authority
WO
WIPO (PCT)
Prior art keywords
salusin
drug containing
drug
intended
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/069307
Other languages
English (en)
Japanese (ja)
Inventor
Masayoshi Shichiri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ProteinExpress Co Ltd
Tokyo Medical and Dental University NUC
Original Assignee
ProteinExpress Co Ltd
Tokyo Medical and Dental University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ProteinExpress Co Ltd, Tokyo Medical and Dental University NUC filed Critical ProteinExpress Co Ltd
Publication of WO2009054483A1 publication Critical patent/WO2009054483A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne un nouveau médicament contenant de la salusine-β comme principe actif.
PCT/JP2008/069307 2007-10-26 2008-10-24 Medicament contenant de la salusine-β Ceased WO2009054483A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007279006 2007-10-26
JP2007-279006 2007-10-26

Publications (1)

Publication Number Publication Date
WO2009054483A1 true WO2009054483A1 (fr) 2009-04-30

Family

ID=40579585

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/069307 Ceased WO2009054483A1 (fr) 2007-10-26 2008-10-24 Medicament contenant de la salusine-β

Country Status (1)

Country Link
WO (1) WO2009054483A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016222630A (ja) * 2015-06-03 2016-12-28 学校法人北里研究所 血管新生関連疾患の治療又は予防剤、スクリーニング方法及びキット
JP2019076117A (ja) * 2019-02-18 2019-05-23 学校法人北里研究所 血管新生関連疾患の治療又は予防剤のスクリーニング方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005095609A1 (fr) * 2004-04-02 2005-10-13 Japan Science And Technology Agency Nouveau peptide endogene cardio-inhibiteur/antihypertenseur physiologiquement actif

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005095609A1 (fr) * 2004-04-02 2005-10-13 Japan Science And Technology Agency Nouveau peptide endogene cardio-inhibiteur/antihypertenseur physiologiquement actif

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SHICHIRI M., ENDOCRINOLOGY & DIABETOLOGY, vol. 22, no. 4, 2006, pages 459 - 463 *
ZHIWEI WANG, EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 539, 2006, pages 145 - 150 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016222630A (ja) * 2015-06-03 2016-12-28 学校法人北里研究所 血管新生関連疾患の治療又は予防剤、スクリーニング方法及びキット
JP2019076117A (ja) * 2019-02-18 2019-05-23 学校法人北里研究所 血管新生関連疾患の治療又は予防剤のスクリーニング方法

Similar Documents

Publication Publication Date Title
USD688556S1 (en) Bottle cap
USD582633S1 (en) Pocket
USD591029S1 (en) Pocket
WO2010030598A3 (fr) Formulations pharmaceutiques comprenant du pemetrexed
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
WO2009039951A3 (fr) Associations de principes actifs à propriétés insecticides et acaricides
WO2008131114A3 (fr) Formulations pharmaceutiques contenant des dérivés d'acide lipoïque
WO2009057079A3 (fr) Nouveaux dérivés de pyrimidine
EP1888728A4 (fr) Analogues d'acides gras, autrement dit derives dha utilises comme medicament
EP2172238A4 (fr) Injecteur de solution de médicament
WO2009030469A8 (fr) Nouveaux fongicides
WO2011120904A3 (fr) Composition pharmaceutique à dissolution rapide
WO2008006528A3 (fr) Nouvelles compositions pharmaceutiques comprenant du lévétiracétam
EP2058024A4 (fr) Vaporisateur médical
TW200942524A (en) Novel aminomethyl benzene derivatives
WO2011009938A3 (fr) Stambomycine et dérivés, leur production et leur utilisation comme médicaments
WO2008116147A3 (fr) Compositions structurées comprenant une argile
WO2011120903A3 (fr) Composition pharmaceutique à dissolution rapide
WO2009055289A3 (fr) Lactames substitués à usage thérapeutique
EA200900958A1 (ru) Препарат невирапина пролонгированного высвобождения
WO2007138562A3 (fr) Compositions de parfum concentrée
WO2009103813A3 (fr) Compositions fongicides contenant du 3'-bromo-2,3,4,6'-tétraméthoxy-2'-6-diméthylbenzophénone
WO2009156724A3 (fr) Nouveaux composés
WO2008146883A1 (fr) Agent d'amélioration du sommeil
WO2009075250A1 (fr) Agent phytosanitaire

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08841805

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08841805

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP